AZONE TS Trademark

Trademark Overview

On Monday, October 2, 2006, a trademark application was filed for AZONE TS with the United States Patent and Trademark Office. The USPTO has given the AZONE TS trademark a serial number of 77011531. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 6, 2010. This trademark is owned by DP Pharmaceuticals, LLC. The AZONE TS trademark is filed in the Chemical Products category with the following description:

Chemicals, namely, penetration enhancers for use with chemicals, diagnostic, cosmetic, therapeutic and fungicidal agents
azone ts

General Information

Serial Number77011531
Word MarkAZONE TS
Filing DateMonday, October 2, 2006
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 6, 2010
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 14, 2007

Trademark Statements

Goods and ServicesChemicals, namely, penetration enhancers for use with chemicals, diagnostic, cosmetic, therapeutic and fungicidal agents
Pseudo MarkA ZONE TS

Classification Information

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateThursday, October 5, 2006
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameECHO THERAPEUTICS, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressFRANKLIN, MA 02038
Party NameDP Pharmaceuticals, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressDurham, NC 22713
Party NameDP Pharmaceuticals, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressDurham, NC 22713

Trademark Events

Event DateEvent Description
Monday, December 6, 2010ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, December 6, 2010ABANDONMENT - NO USE STATEMENT FILED
Friday, May 14, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Thursday, May 13, 2010EXTENSION 5 GRANTED
Thursday, May 6, 2010EXTENSION 5 FILED
Thursday, May 6, 2010TEAS EXTENSION RECEIVED
Monday, November 9, 2009EXTENSION 4 GRANTED
Friday, November 6, 2009EXTENSION 4 FILED
Friday, November 6, 2009TEAS EXTENSION RECEIVED
Wednesday, May 6, 2009EXTENSION 3 GRANTED
Wednesday, May 6, 2009EXTENSION 3 FILED
Wednesday, May 6, 2009TEAS EXTENSION RECEIVED
Wednesday, February 25, 2009AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Saturday, November 8, 2008EXTENSION 2 GRANTED
Thursday, November 6, 2008EXTENSION 2 FILED
Saturday, November 8, 2008CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, November 6, 2008TEAS EXTENSION RECEIVED
Tuesday, May 6, 2008EXTENSION 1 GRANTED
Tuesday, May 6, 2008EXTENSION 1 FILED
Tuesday, May 6, 2008TEAS EXTENSION RECEIVED
Tuesday, November 6, 2007NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 14, 2007PUBLISHED FOR OPPOSITION
Wednesday, July 25, 2007NOTICE OF PUBLICATION
Tuesday, July 10, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, July 6, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 14, 2007TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 14, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 14, 2007ASSIGNED TO LIE
Wednesday, May 30, 2007TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 27, 2007NON-FINAL ACTION MAILED
Tuesday, February 27, 2007NON-FINAL ACTION WRITTEN
Tuesday, February 20, 2007ASSIGNED TO EXAMINER
Friday, October 6, 2006NOTICE OF PSEUDO MARK MAILED
Thursday, October 5, 2006NEW APPLICATION ENTERED IN TRAM

Related Keywords

azone chemicals therapeutic fungicidal agents cosmetic diagnostic namely penetration enhancers